James M Mock's most recent trade in Moderna Inc was a trade of 11,797 Common Stock done . Disclosure was reported to the exchange on March 5, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Moderna | James M Mock | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Mar 2026 | 11,797 | 62,702 (0%) | 0% | - | Common Stock | |
| Moderna | James M Mock | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Mar 2026 | 11,797 | 129,774 | - | - | Restricted Stock Units | |
| Moderna | James M Mock | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 57.80 per share. | 05 Mar 2026 | 5,704 | 56,998 (0%) | 0% | 57.8 | 329,691 | Common Stock |
| Moderna | James M Mock | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2026 | 49,569 | 49,569 | - | - | Restricted Stock Units | |
| Moderna | James M Mock | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2026 | 37,639 | 37,639 | - | - | Stock Option (Right to Buy) | |
| Moderna | James M Mock | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Feb 2026 | 9,901 | 55,693 (0%) | 0% | - | Common Stock | |
| Moderna | James M Mock | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Feb 2026 | 9,901 | 29,705 | - | - | Restricted Stock Units | |
| Moderna | James M Mock | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 51.71 per share. | 27 Feb 2026 | 4,788 | 50,905 (0%) | 0% | 51.7 | 247,587 | Common Stock |
| Moderna | James M Mock | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Feb 2026 | 774 | 46,167 (0%) | 0% | - | Common Stock | |
| Moderna | James M Mock | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Feb 2026 | 774 | 6,189 | - | - | Restricted Stock Units | |
| Moderna | James M Mock | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 51.71 per share. | 27 Feb 2026 | 375 | 45,792 (0%) | 0% | 51.7 | 19,391 | Common Stock |
| Moderna | James M Mock | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Feb 2026 | 329 | 45,553 (0%) | 0% | - | Common Stock | |
| Moderna | James M Mock | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Feb 2026 | 329 | 1,315 | - | - | Restricted Stock Units | |
| Moderna | James M Mock | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 51.71 per share. | 27 Feb 2026 | 160 | 45,393 (0%) | 0% | 51.7 | 8,274 | Common Stock |
| Moderna | James M Mock | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2026 | 2,630 | 46,502 (0%) | 0% | 0 | Common Stock | |
| Moderna | James M Mock | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 41.99 per share. | 11 Feb 2026 | 1,278 | 45,224 (0%) | 0% | 42.0 | 53,663 | Common Stock |
| Moderna | James M Mock | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jan 2026 | 1,452 | 44,652 (0%) | 0% | - | Common Stock | |
| Moderna | James M Mock | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jan 2026 | 1,452 | 4,359 | - | - | Restricted Stock Units | |
| Moderna | James M Mock | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 30.86 per share. | 05 Jan 2026 | 780 | 43,872 (0%) | 0% | 30.9 | 24,071 | Common Stock |
| Moderna | James M Mock | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Dec 2025 | 47,190 | 66,017 (0%) | 0% | - | Common Stock | |
| Moderna | James M Mock | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Dec 2025 | 47,190 | 141,571 | - | - | Restricted Stock Units | |
| Moderna | James M Mock | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 25.49 per share. | 05 Dec 2025 | 22,817 | 43,200 (0%) | 0% | 25.5 | 581,605 | Common Stock |
| Moderna | James M Mock | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Nov 2025 | 773 | 19,032 (0%) | 0% | - | Common Stock | |
| Moderna | James M Mock | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Nov 2025 | 773 | 6,963 | - | - | Restricted Stock Units | |
| Moderna | James M Mock | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 24.75 per share. | 26 Nov 2025 | 374 | 18,658 (0%) | 0% | 24.8 | 9,257 | Common Stock |
| Moderna | James M Mock | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Nov 2025 | 329 | 1,644 | - | - | Restricted Stock Units | |
| Moderna | James M Mock | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Nov 2025 | 329 | 18,987 (0%) | 0% | - | Common Stock | |
| Moderna | James M Mock | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 25.01 per share. | 26 Nov 2025 | 160 | 18,827 (0%) | 0% | 25.0 | 4,002 | Common Stock |
| Moderna | James M Mock | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Oct 2025 | 1,453 | 18,962 (0%) | 0% | - | Common Stock | |
| Moderna | James M Mock | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Oct 2025 | 1,453 | 5,811 | - | - | Restricted Stock Units | |
| Moderna | James M Mock | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 28.37 per share. | 03 Oct 2025 | 703 | 18,259 (0%) | 0% | 28.4 | 19,944 | Common Stock |
| Moderna | James M Mock | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Aug 2025 | 774 | 17,715 (0%) | 0% | - | Common Stock | |
| Moderna | James M Mock | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Aug 2025 | 774 | 7,736 | - | - | Restricted Stock Units | |
| Moderna | James M Mock | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 24.73 per share. | 27 Aug 2025 | 375 | 17,340 (0%) | 0% | 24.7 | 9,274 | Common Stock |
| Moderna | James M Mock | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Aug 2025 | 329 | 1,973 | - | - | Restricted Stock Units | |
| Moderna | James M Mock | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Aug 2025 | 329 | 17,669 (0%) | 0% | - | Common Stock | |
| Moderna | James M Mock | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 25.10 per share. | 27 Aug 2025 | 160 | 17,509 (0%) | 0% | 25.1 | 4,016 | Common Stock |
| Moderna | James M Mock | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jul 2025 | 1,453 | 17,644 (0%) | 0% | - | Common Stock | |
| Moderna | James M Mock | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jul 2025 | 1,453 | 7,264 | - | - | Restricted Stock Units | |
| Moderna | James M Mock | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 30.28 per share. | 03 Jul 2025 | 703 | 16,941 (0%) | 0% | 30.3 | 21,287 | Common Stock |
| Moderna | James M Mock | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 May 2025 | 773 | 8,510 | - | - | Restricted Stock Units | |
| Moderna | James M Mock | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 May 2025 | 773 | 16,396 (0%) | 0% | - | Common Stock | |
| Moderna | James M Mock | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 26.26 per share. | 27 May 2025 | 374 | 16,022 (0%) | 0% | 26.3 | 9,821 | Common Stock |
| Moderna | James M Mock | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 May 2025 | 328 | 16,350 (0%) | 0% | - | Common Stock | |
| Moderna | James M Mock | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 May 2025 | 328 | 2,302 | - | - | Restricted Stock Units | |
| Moderna | James M Mock | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 26.76 per share. | 27 May 2025 | 159 | 16,191 (0%) | 0% | 26.8 | 4,255 | Common Stock |
| Moderna | James M Mock | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Apr 2025 | 1,452 | 8,717 | - | - | Restricted Stock Units | |
| Moderna | James M Mock | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Apr 2025 | 1,452 | 16,326 (0%) | 0% | - | Common Stock | |
| Moderna | James M Mock | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 25.73 per share. | 04 Apr 2025 | 703 | 15,623 (0%) | 0% | 25.7 | 18,088 | Common Stock |
| Moderna | James M Mock | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 63,478 | 63,478 | - | - | Stock Option (Right to Buy) | |
| Moderna | James M Mock | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 39,606 | 39,606 | - | - | Restricted Stock Units | |
| Moderna | James M Mock | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2025 | 329 | 15,034 (0%) | 0% | - | Common Stock | |
| Moderna | James M Mock | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2025 | 329 | 2,630 | - | - | Restricted Stock Units | |
| Moderna | James M Mock | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 31.09 per share. | 28 Feb 2025 | 160 | 14,874 (0%) | 0% | 31.1 | 4,974 | Common Stock |
| Moderna | James M Mock | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Feb 2025 | 3,094 | 9,283 | - | - | Restricted Stock Units | |
| Moderna | James M Mock | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Feb 2025 | 3,094 | 15,517 (0%) | 0% | - | Common Stock | |
| Moderna | James M Mock | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 33.58 per share. | 27 Feb 2025 | 1,496 | 14,021 (0%) | 0% | 33.6 | 50,236 | Common Stock |
| Moderna | James M Mock | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Feb 2025 | 1,326 | 13,065 (0%) | 0% | - | Common Stock | |
| Moderna | James M Mock | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Feb 2025 | 1,326 | 0 | - | - | Restricted Stock Units | |
| Moderna | James M Mock | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Feb 2025 | 1,326 | 0 | - | - | Performance Stock Units | |
| Moderna | James M Mock | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Feb 2025 | 1,326 | 15,347 (0%) | 0% | - | Common Stock | |
| Moderna | James M Mock | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 33.58 per share. | 27 Feb 2025 | 642 | 14,705 (0%) | 0% | 33.6 | 21,558 | Common Stock |
| Moderna | James M Mock | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 33.58 per share. | 27 Feb 2025 | 642 | 12,423 (0%) | 0% | 33.6 | 21,558 | Common Stock |
| Moderna | James M Mock | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jan 2025 | 1,453 | 12,519 (0%) | 0% | - | Common Stock | |
| Moderna | James M Mock | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jan 2025 | 1,453 | 10,169 | - | - | Restricted Stock Units | |
| Moderna | James M Mock | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 42.00 per share. | 03 Jan 2025 | 780 | 11,739 (0%) | 0% | 42 | 32,760 | Common Stock |
| Moderna | James M Mock | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Dec 2024 | 188,761 | 188,761 | - | - | Restricted Stock Units | |
| Moderna | James M Mock | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 42.79 per share. | 27 Nov 2024 | 1,420 | 11,066 (0%) | 0% | 42.8 | 60,761 | Common Stock |
| Moderna | James M Mock | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Nov 2024 | 1,326 | 1,326 | - | - | Restricted Stock Units | |
| Moderna | James M Mock | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Nov 2024 | 1,326 | 1,326 | - | - | Performance Stock Units | |
| Moderna | James M Mock | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Nov 2024 | 1,326 | 12,486 (0%) | 0% | - | Common Stock | |
| Moderna | James M Mock | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Nov 2024 | 1,326 | 10,831 (0%) | 0% | - | Common Stock | |
| Moderna | James M Mock | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Nov 2024 | 329 | 2,959 | - | - | Restricted Stock Units | |
| Moderna | James M Mock | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Nov 2024 | 329 | 11,160 (0%) | 0% | - | Common Stock | |
| Moderna | James M Mock | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Oct 2024 | 1,453 | 11,622 | - | - | Restricted Stock Units | |
| Moderna | James M Mock | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Oct 2024 | 1,453 | 10,220 (0%) | 0% | - | Common Stock | |
| Moderna | James M Mock | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 60.12 per share. | 04 Oct 2024 | 715 | 9,505 (0%) | 0% | 60.1 | 42,986 | Common Stock |
| Moderna | James M Mock | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Aug 2024 | 329 | 3,288 | - | - | Restricted Stock Units | |
| Moderna | James M Mock | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Aug 2024 | 329 | 8,929 (0%) | 0% | - | Common Stock | |
| Moderna | James M Mock | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 78.02 per share. | 28 Aug 2024 | 162 | 8,767 (0%) | 0% | 78.0 | 12,640 | Common Stock |
| Moderna | James M Mock | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Aug 2024 | 1,326 | 8,595 (0%) | 0% | - | Common Stock | |
| Moderna | James M Mock | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Aug 2024 | 1,326 | 2,652 | - | - | Restricted Stock Units | |
| Moderna | James M Mock | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Aug 2024 | 1,326 | 2,652 | - | - | Performance Stock Units | |
| Moderna | James M Mock | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Aug 2024 | 1,326 | 9,921 (0%) | 0% | - | Common Stock | |
| Moderna | James M Mock | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 79.40 per share. | 27 Aug 2024 | 1,321 | 8,600 (0%) | 0% | 79.4 | 104,881 | Common Stock |
| Moderna | James M Mock | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jul 2024 | 1,452 | 13,075 | - | - | Restricted Stock Units | |
| Moderna | James M Mock | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jul 2024 | 1,452 | 7,958 (0%) | 0% | - | Common Stock | |
| Moderna | James M Mock | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 118.24 per share. | 05 Jul 2024 | 689 | 7,269 (0%) | 0% | 118.2 | 81,465 | Common Stock |
| Moderna | James M Mock | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2024 | 5,304 | 5,304 | - | - | Performance Stock Units | |
| Moderna | James M Mock | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 May 2024 | 1,326 | 3,978 | - | - | Performance Stock Units | |
| Moderna | James M Mock | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 May 2024 | 1,326 | 7,197 (0%) | 0% | - | Common Stock | |
| Moderna | James M Mock | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 140.72 per share. | 31 May 2024 | 691 | 6,506 (0%) | 0% | 140.7 | 97,237 | Common Stock |
| Moderna | James M Mock | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 May 2024 | 328 | 6,054 (0%) | 0% | - | Common Stock | |
| Moderna | James M Mock | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 May 2024 | 328 | 3,617 | - | - | Restricted Stock Units | |
| Moderna | James M Mock | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 144.50 per share. | 28 May 2024 | 183 | 5,871 (0%) | 0% | 144.5 | 26,444 | Common Stock |
| Moderna | James M Mock | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 May 2024 | 1,326 | 6,374 (0%) | 0% | - | Common Stock | |
| Moderna | James M Mock | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 May 2024 | 1,326 | 3,978 | - | - | Restricted Stock Units | |
| Moderna | James M Mock | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 162.47 per share. | 24 May 2024 | 648 | 5,726 (0%) | 0% | 162.5 | 105,283 | Common Stock |
| Moderna | James M Mock | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Apr 2024 | 1,453 | 5,753 (0%) | 0% | - | Common Stock | |
| Moderna | James M Mock | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Apr 2024 | 1,453 | 14,527 | - | - | Restricted Stock Units | |
| Moderna | James M Mock | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 101.93 per share. | 05 Apr 2024 | 705 | 5,048 (0%) | 0% | 101.9 | 71,859 | Common Stock |